Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sofwave MedicalSOFWF 51 3-Year EBITDA Growth Rate is 0.00% as of Mar. 2026. GuruFocus rates SOFWF with a GF Score™ of 51/100 and a GF Value™ of $10.06 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 690 Medical Devices & Instruments companies, Sofwave Medical ranks worse than 144927.39% on this metric.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 8 years, the highest 3-Year average EBITDA Per Share Growth Rate of Sofwave Medical was 38.40% per year. The lowest was -76.70% per year. And the median was 16.30% per year.
Sofwave Medical (OTCPK:SOFWF) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Sofwave Medical 3-Year EBITDA Growth Rate Related Terms
SOFWF vs ABT, SYK, MDT: 3-Year EBITDA Growth Rate Comparison
For the Medical Devices subindustry, Sofwave Medical's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sofwave Medical 3-Year EBITDA Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sofwave Medical's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Sofwave Medical's 3-Year EBITDA Growth Rate falls into.
Sofwave Medical 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 0.00% mean?
Sofwave Medical (SOFWF) has a 3-Year EBITDA Growth Rate of 0.00% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Sofwave Medical and its competitors. According to the industry distribution chart, Sofwave Medical ranks #999999 out of 690 companies in the Medical Devices & Instruments industry.
Is Sofwave Medical's 3-Year EBITDA Growth Rate too high?
Sofwave Medical's current 3-Year EBITDA Growth Rate is 0.00%. Based on the distribution chart, Sofwave Medical ranks #999999 out of 690 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sofwave Medical has a GF Score™ of 51/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sofwave Medical's 3-Year EBITDA Growth Rate compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sofwave Medical ranks #999999 out of 690 companies for 3-Year EBITDA Growth Rate. This places Sofwave Medical in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 8.35. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EBITDA Growth Rate among Medical Devices & Instruments companies is 8.35, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Sofwave Medical and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EBITDA Growth Rate is 8.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sofwave Medical's current 3-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sofwave Medical stock overvalued right now?
Based on GuruFocus' analysis, Sofwave Medical (SOFWF) is currently considered Modestly Overvalued. The stock's GF Value™ is $10.06, compared to a current price of $11.63 — trading 15.6% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 0.00%. Sofwave Medical's overall GF Score™ is 51/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Sofwave Medical (SOFWF), the current 3-Year EBITDA Growth Rate is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sofwave Medical (SOFWF) Overvalued in 2026?
Based on GuruFocus' analysis, Sofwave Medical stock appears to be overvalued.
The current stock price of $11.63 is trading 15.6% above its estimated GF Value™ of $10.06.
GuruFocus considers Sofwave Medical to be Modestly Overvalued.
Key valuation signals for SOFWF:
3-Year EBITDA Growth Rate: 0.00%
GF Value™: $10.06 vs. price of $11.63 (15.6% above fair value)
No single metric tells the full story. See the SOFWF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SOFWF has been successfully added to your 
